Mueller L

Division of Clinical Pharmacology and Toxicology, Department of Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland.

8 papers · ORCID

ArticleLSD

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Haijen-Bongers ECHM, Hurks PPM, Schepers J +6

Europe PMC2026
ArticleMDMA

Comparison of acute effects of 3,4-methylenedioxymethamphetamine (MDMA) with and without a supplemental booster dose in healthy participants: a double-blind, randomized, placebo-controlled, crossover study.

Humbert-Droz M, Becker AM, Valenta J +6

Europe PMC2026
ArticleDMT

Dose-dependent pharmacokinetics and acute effects of intravenous bolus N,N-dimethyltryptamine: double-blind, randomized versus open-label dose-escalation administration study in healthy participants.

Erne L, Mueller L, Straumann I +7

Europe PMC2026
ArticleMescaline

Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants.

Mueller L, Klaiber A, Ley L +5

Europe PMC2025
ArticleLSD

Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults: A Randomized Clinical Trial.

Mueller L, Santos de Jesus J, Schmid Y +9

Europe PMC2025
ArticleLSD

Absolute Oral Bioavailability and Bioequivalence of LSD Base and Tartrate in a Double-Blind, Placebo-Controlled, Crossover Study.

Arikci D, Holze F, Mueller L +5

Europe PMC2025
ArticleLSD

Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.

Becker AM, Humbert-Droz M, Mueller L +10

Europe PMC2025
ArticleDMT

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants.

Vogt SB, Ley L, Erne L +12

Europe PMC2023